Cationic liposome-mediated delivery of siRNAs in adult mice

Biochemical and Biophysical Research Communications

Volumn 312, Issue 4, 2003, Pages 1220-1225

  Sioud, Mouldy ^a   Sørensen, Dag R ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cationic liposomes; Innate immunity; Long double stranded RNA; RNA interference; siRNA; TNF

Indexed keywords

CATION; FLUORESCEIN; INTERLEUKIN 6; LIPOSOME; RNA; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER THERAPY; CELL ISOLATION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG TARGETING; GENE SEQUENCE; IMMUNE RESPONSE; IN VIVO STUDY; LIPID TRANSPORT; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; VALIDATION PROCESS;

EID: 0344926320     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.11.057     Document Type: Article

References (17)

1. Sioud M. Nucleic acid enzymes as a novel generation of anti-gene agents. Curr. Mol. Med. 1:2001;575-588.
2. Hannon G.J. RNA interference. Nature. 418:2002;244-251.
3. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 391:1998;806-811.
4. Sen G.C. Viruses and interferons. Annu. Rev. Microbiol. 55:2001;255-281.
5. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:2001;494-498.
6. Schwarz D.S.et al. Evidence that siRNA function as guides, not primers, in the Drosophila and human RNAi pathways. Mol. Cell. 10:2003;537-548.
7. Templeton S.N. Liposomal delivery of nucleic acids in vivo. DNA Cell. Biol. 21:2002;859-867.
8. Ulrich A.S. Biophysical aspects of using liposomes as delivery vehicles. Biosci. Rep. 22:2002;129-150.
9. Timme T.L., Satoh T., Tahir S.A., Wang H., The B.S., Butler E.B., Miles B.J., Amato R.J., Kadmon D., Thompson T.C. Therapeutic targets for metastatic prostate cancer. Curr. Drug Targets. 4:2003;251-261.
10. Harborth J.et al. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Antisense Nucleic Acid Drug Dev. 13:2003;83-105.
11. Sørensen D.R., Leirdal M., Sioud M. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J. Mol. Biol. 327:2003;761-766.
12. Tracey K.J., Carami A. Tumour necrosis factor: a pleiotropic cytokine and therapeutic target. Annu. Rev. Med. 45:1994;491-503.
13. Sun L.Q., Cairns M.J., Saravolac E.G., Baker A., Gerlach W.L. Catalyic nucleic acids: from lab to applications. Pharmacol. Rev. 52:2000;325-347.
14. Muggia F., Hamilton A. Phase III data on Caelyx in ovarian cancer. Eur. J. Cancer. 37:2001;S15-S18.
15. Sledz C.A., Holko M., de Veer M.J., Silverman R.H., Williams B.R.G. Activation of the interferon system by short-interfering RNAs. Nat. Cell. Biol. 5:2003;834-839.
16. Alexopoulou L., Holt A.C., Medzhitov R., Flavel R.A. Recognition of double-stranded RNA and activation of NF-κ B by Toll-like receptor 3. Nature. 413:2001;732-738.
17. Sioud M., Sørensen D.R. Generation of an effective anti-tumor immunity after immunization with xenogeneic antigens. Eur. J. Immunol. 33:2003;38-45.